Evaluation of Vascular Endothelial Growth Factor A and Selected Parameters of Coagulation and Fibrinolysis in a Group of Patients with Subarachnoid Haemorrhage

Abstract EN

Introduction.

Subarachnoid hemorrhage (SAH) is currently one of the most serious diseases of the central nervous system.

To reduce the negative consequences of SAH and help clinicians to assess the patient’s condition, there are attempts to search for new diagnostic markers, which quickly and accurately allow for the proper diagnosis.

The aim of this research was the concentration and activity of Vascular Endothelial Growth Factor A (VEGF-A) and selected parameters of coagulation and fibrinolysis in the blood of patients with SAH.

Serum levels of VEGF-A in patients diagnosed with SAH are measured to assess the correlation between VEGF-A and the clinical condition of patient.

This may help with proper therapeutics and better prognosis.

Methods.

The study involved 85 patients with subarachnoid hemorrhage.

The control group consisted of 45 healthy subjects, sex and age matched.

The following parameters were determined: APTT (Activated Partial Thromboplastin Time), INR (International Normalized Ratio), D-dimers and fibrinogen concentration, and the concentration of VEGF-A by ELISA (R&D USA).

Results.

The average concentration of VEGF-A in the study group was significantly lower compared to the control group.

The D-dimer concentration was higher in patients with SAH but the difference was not significant.

Coagulation parameters such as INR, APTT, and fibrinogen did not show significant differences between investigated groups.

Conclusions.

VEGF-A cannot be an independent marker of SAH.

Selected parameters of coagulation and fibrinolysis such as D-dimers, INR, APTT, and fibrinogen should not be used as markers of SAH.